# Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH)

> **NCT00120380** · PHASE4 · TERMINATED · sponsor: **Hannover Medical School** · enrollment: 40 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Aerosolized iloprost
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00120380
- **Lead sponsor:** Hannover Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-09
- **Primary completion:** 2006-05
- **Final completion:** 2006-05
- **Target enrollment:** 40 (ACTUAL)
- **Why stopped:** Futility analysis
- **Last updated:** 2012-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00120380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00120380, "Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH)". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00120380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*